Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy
Constantin‐Cristian Topriceanu(University College London), Gabrielle Norrish(Cardiovascular Institute of the South), Elena Cervi(Great Ormond Street Hospital), Ella Field(Great Ormond Street Hospital), Juan Pablo Kaski(Great Ormond Street Hospital), Olga Boleti(University College London)
Cited by 11
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
|JAMA Cardiology|2019|248
Artificial Intelligence in Medicine: A Multinational Multi-Center Survey on the Medical and Dental Students' Perception
|Frontiers in Public Health|2021|212
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry
|European Heart Journal|2019|184